Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.
about
Calcium efflux activity of plasma membrane Ca2+ ATPase-4 (PMCA4) mediates cell cycle progression in vascular smooth muscle cellsCell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old playerWnt signalling in smooth muscle cells and its role in cardiovascular disordersInhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic miceNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasGenome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.Store-operated CRAC channels regulate gene expression and proliferation in neural progenitor cells.Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.ERK activation is required for CCK-mediated pancreatic adaptive growth in mice.Two heterozygous mutations in NFATC1 in a patient with Tricuspid Atresia.Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L.Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashionNuclear factor of activated T-cell isoform expression and regulation in human myometriumProtein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodelingMicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAPMicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall reTargeting TRPC6 channels in oesophageal carcinoma growth.Estrogen controls embryonic stem cell proliferation via store-operated calcium entry and the nuclear factor of activated T-cells (NFAT).Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia.p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation.MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.Nuclear factor of activated T cells mediates oxidised LDL-induced calcification of vascular smooth muscle cells.Apigenin attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation.
P2860
Q24321930-0759707A-0274-47A3-BC30-6136464CC15DQ26751243-F76C032C-70F7-4BD9-94AE-A7A2D546164DQ26849336-AC86E5E2-3168-4C68-8116-CA4F40ABCAF2Q27317653-0B534744-EE27-4DAA-8DD4-39FDEB797C6DQ28567562-436E8AB4-8000-44BD-95EF-244AA28A23A0Q30424180-7A177DEF-5722-4202-A90D-51E812D3999EQ33832147-10302A54-7E5A-490B-8EF1-8BC1CF4BA294Q34196423-32B4D985-C25D-44A0-B361-98DFFA5F37A3Q34233778-FA572C43-4C34-46ED-B03B-48C5D8EA403DQ34295427-1824BF04-F4BC-4650-A060-9122AFE667B7Q34505005-88422B26-B759-40F7-B15E-290D3594DC1FQ34780528-16ECF388-87BF-4CD4-8288-D775CCB7201FQ34806661-FD3B3457-35A2-4F9F-8E63-D1D1C0504B71Q35122850-22502834-DF8A-4928-9945-A66D598FCDA5Q35913596-39A18280-AFA4-429A-8461-07AD2A039948Q36332889-77EAB985-9B1B-43F4-A0E3-00F9199FAAEDQ36429631-6F5EFC3D-D6E5-46E3-BF52-418A35BD0739Q36943405-894E902A-A7EC-4A1A-B2B6-4E5729B1BBEFQ37048514-DC1D256E-0A19-4F40-9362-03E17B7DCFA6Q37710561-DC457112-1E31-426F-AD43-9D8502B04469Q39478396-8B8EB012-40DE-4F40-B8A9-44DF8C19978DQ42066164-FB44723C-2BD2-4685-9943-6A939E44C14AQ42290877-718D6DBC-A1BE-49E9-AF62-CDC360BC71CCQ50920114-41F3431D-6F35-47C7-ACCD-9CF699287061Q53281676-7D3B9CF0-807D-4DF1-B89E-494F4F6599FBQ54363109-9C326509-7C6B-4B7D-A950-E016CB9AD92DQ54549095-9E3EA617-5E23-4F88-9CFB-784802E3D4EF
P2860
Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@ast
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@en
type
label
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@ast
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@en
prefLabel
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@ast
Cyclin D1 is a bona fide targe ...... uced vascular wall remodeling.
@en
P2093
P2860
P356
P1476
Cyclin D1 is a bona fide targe ...... duced vascular wall remodeling
@en
P2093
Dong Van Quyen
Gadiparthi N Rao
Manjula Karpurapu
Srinidhi Pulusani
Tae-Kang Kim
P2860
P304
P356
10.1074/JBC.M109.063727
P407
P577
2009-11-22T00:00:00Z